Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,949.00
Bid: 1,952.00
Ask: 1,954.00
Change: -24.00 (-1.22%)
Spread: 2.00 (0.102%)
Open: 1,972.00
High: 1,982.00
Low: 1,949.00
Prev. Close: 1,973.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: Goldman And Deutsche Raise Miner Price Targets

Wed, 16th Nov 2016 09:55

LONDON (Alliance News) - The following shares received analyst recommendations Wednesday morning and Tuesday:
----------
FTSE 100
----------
GOLDMAN RAISES RIO TINTO PRICE TARGET TO 3000 (1925) PENCE - 'NEUTRAL'
----------
DEUTSCHE BANK RAISES RIO TINTO PRICE TARGET TO 3500 (3250) PENCE - 'BUY'
----------
GOLDMAN RAISES BHP BILLITON PRICE TARGET TO 1400 (800) PENCE - 'NEUTRAL'
----------
DEUTSCHE BANK RAISES BHP BILLITON PRICE TARGET TO 1350 (1260) PENCE - 'HOLD'
----------
GOLDMAN RAISES ANTOFAGASTA PRICE TARGET TO 500 (300) PENCE - 'SELL'
----------
GOLDMAN RAISES ANGLO AMERICAN TO 'BUY' ('SELL') - TARGET 1400 (400) PENCE
----------
DEUTSCHE BANK RAISES ANGLO AMERICAN PRICE TARGET TO 1200 (965) PENCE - 'HOLD'
----------
Numis Upgrades Fresnillo To Hold From Reduce, Target At 1,400p
----------
S&P GLOBAL RAISES PRUDENTIAL PRICE TARGET TO 1680 (1600) PENCE - 'BUY'
----------
PANMURE RAISES PRUDENTIAL PRICE TARGET TO 1850 (1610) PENCE - 'BUY'
----------
JPMORGAN CUTS VODAFONE PRICE TARGET TO 285 (295) PENCE - 'OVERWEIGHT'
----------
LBBW RAISES VODAFONE TO 'BUY' (HOLD) - PRICE TARGET 250 (220) PENCE
----------
SOCGEN CUTS ASTRAZENECA PRICE TARGET TO 6500 (7000) PENCE - 'BUY'
----------
MORGAN STANLEY RAISES HIKMA TO 'OVERWEIGHT' ('EQUAL-WEIGHT')- TARGET 2200 (2500) PENCE
----------
JPMORGAN RAISES SMITHS GROUP PRICE TARGET TO 1,612 (1,600) PENCE - 'OVERWEIGHT'
----------
CITIGROUP RAISES UNITED UTILITIES TO 'NEUTRAL' ('SELL')
----------
CITIGROUP RAISES SEVERN TRENT TO 'NEUTRAL' ('SELL')
----------
CITIGROUP CUTS CENTRICA TO 'SELL' - TARGET 175 PENCE
----------
HSBC RAISES EASYJET PRICE TARGET TO 1300 (1150) PENCE - 'BUY'
----------
S&P GLOBAL RAISES EASYJET PRICE TARGET TO 1200 (1000) PENCE - 'HOLD'
----------
GOLDMAN RAISES LAND SECURITIES PRICE TARGET TO 1185 (1175) PENCE - 'NEUTRAL'
----------
S&P GLOBAL CUTS LAND SECURITIES PRICE TARGET TO 900 (1000) PENCE - 'SELL'
----------
FTSE 250
----------
Numis Cuts ICAP To Hold From Buy, Target At 500p
----------
Numis Cuts Jupiter Fund Management To Add From Buy, Target 520p From 545p
----------
HSBC CUTS B&M EUROPEAN VALUE RETAIL PRICE TARGET TO 350 (370) PENCE - 'BUY'
----------
JEFFERIES RAISES B&M EUROPEAN VALUE RETAIL TARGET TO 285 (265) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES VEDANTA RESOURCES PRICE TARGET TO 905 (900) PENCE - 'HOLD'
----------
GOLDMAN INITIATES VEDANTA RESOURCES WITH 'CONVICTION BUY LIST'; TARGET 1300 PENCE
----------
JPMORGAN CUTS MEGGITT PRICE TARGET TO 465 (470) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS BTG PRICE TARGET TO 800 (830) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES FIRSTGROUP PRICE TARGET TO 141 (140) PENCE - 'OVERWEIGHT'
----------
JEFFERIES CUTS MCCARTHY & STONE PRICE TARGET TO 246 (249) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES MCCARTHY & STONE PRICE TARGET TO 219 (216) PENCE - 'HOLD'
----------
CITIGROUP RAISES PENNON GROUP TO 'NEUTRAL' ('SELL')
----------
Investec Ups Cranswick To 2,540p From 2,520p, Keeps Buy
----------
HSBC RAISES WIZZ AIR PRICE TARGET TO 1250 (1100) PENCE - 'REDUCE'
----------
HSBC RAISES ELECTROCOMPONENTS TO 'BUY' ('HOLD') - TARGET 430 (240) PENCE
----------
BERENBERG RAISES WILLIAM HILL PRICE TARGET TO 275 (255) PENCE - 'SELL'
----------
MAIN MARKET AND AIM
----------
Numis Lifts Oxford Instruments To Add From Hold, Cuts Price Target To 750p From 815p
----------
DEUTSCHE BANK RAISES SOUTH32 PRICE TARGET TO 148 (122) PENCE - 'HOLD'
----------
DEUTSCHE BANK RAISES FERREXPO PRICE TARGET TO 205 (185) PENCE - 'BUY'
----------
SHORE CAPITAL CUTS BROOKS MACDONALD FAIR VALUE TO 1875 (2000) PENCE - 'HOLD'
----------
finnCap Upgrades Carclo To Buy From Hold, Target 138p
----------
Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more
4 Nov 2021 09:03

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

TOP NEWS: Hikma confirms 2021 guidance amid strong performance

Read more
4 Nov 2021 07:58

Hikma reports solid trading in year to date

(Sharecast News) - Hikma Pharmaceuticals reiterated full-year guidance as the company reported solid trading across its business.

Read more
1 Nov 2021 13:52

Citi sees room for upside surprise on sales at Hikma Pharmaceuticals

(Sharecast News) - Analysts at Citi reiterated their 'buy' stance for shares of Hikma Pharmaceuticals ahead of the company's trading statement due out later in the same week.

Read more
28 Oct 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
20 Oct 2021 09:51

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

LONDON BROKER RATINGS: BofA cuts Hammerson and upgrades Capco

Read more
27 Sep 2021 12:14

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

LONDON MARKET MIDDAY: Gains ebb; crunch time for US spending bills

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.